Clinical trial · Observational

Studying Genes in Samples From Younger Patients With Adrenocortical Tumor

Using New Approaches for Genomics Studies in Pediatric Adrenocortical Tumors: Whole Genome Sequencing; Deep Sequencing; miRNA; methDNA and SNP 6.0

NCT01528956CI-TRIAL-00022237completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies genes in samples from younger patients with adrenocortical tumor.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Adrenocortical Carcinoma	Adrenal Cortical Carcinoma	ALIAS	0.90

Interventions

Interventions (5)

Intervention	Type	Mapped drug	Match
DNA methylation analysis	Genetic	—	UNRESOLVED
gene expression analysis	Genetic	—	UNRESOLVED
nucleic acid sequencing	Genetic	—	UNRESOLVED
polymorphism analysis	Genetic	—	UNRESOLVED
RNA analysis	Genetic	—	UNRESOLVED

Design

Arms and outcomes

Arms (0)

[]

Primary outcomes (2)

measure
Identification of genetic factors affecting adrenocortical tumors
measure
Comprehensive catalog of altered genes in adrenocortical samples

Eligibility

Eligibility (as posted)

Sex: All
Maximum age: 21 Years

Show eligibility criteria text

DISEASE CHARACTERISTICS:

* Banked tumor and blood samples obtained from patients enrolled on COG-ARAR0332 in North America and Brazil

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

References

Publications (0)

Data not yet available

No reference posted for this study.